94 related articles for article (PubMed ID: 1997938)
1. Expression of c-myc gene product in gastric carcinoma.
Ninomiya I; Yonemura Y; Matsumoto H; Sugiyama K; Kamata T; Miwa K; Miyazaki I; Shiku H
Oncology; 1991; 48(2):149-53. PubMed ID: 1997938
[TBL] [Abstract][Full Text] [Related]
2. c-Myc expression is related with cell proliferation and associated with poor clinical outcome in human gastric cancer.
Han S; Kim HY; Park K; Cho HJ; Lee MS; Kim HJ; Kim YD
J Korean Med Sci; 1999 Oct; 14(5):526-30. PubMed ID: 10576148
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical detection of the c-myc oncogene product in normal, hyperplastic and carcinomatous endometrium.
Bai MK; Costopoulos JS; Christoforidou BP; Papadimitriou CS
Oncology; 1994; 51(4):314-9. PubMed ID: 8208512
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical detection of c-myc oncogene product in human gastric carcinomas: expression in tumor cells and stromal cells.
Yamamoto T; Yasui W; Ochiai A; Ito H; Abe K; Yanaihara N; Tahara E
Jpn J Cancer Res; 1987 Nov; 78(11):1169-74. PubMed ID: 2447046
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the ras and myc oncoproteins in benign gastric lesions.
Karayiannis M; Yiagnisis M; Papadimitriou K; Field JK; Spandidos DA
Anticancer Res; 1990; 10(5A):1127-33. PubMed ID: 2241094
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of c-myc proto-oncogene in primary human breast carcinomas.
Pavelic ZP; Steele P; Preisler HD
Anticancer Res; 1991; 11(4):1421-7. PubMed ID: 1660688
[TBL] [Abstract][Full Text] [Related]
7. c-myc, c-erbB-2, and Ki-67 expression in normal breast tissue and in invasive and noninvasive breast carcinoma.
Pavelic ZP; Pavelic L; Lower EE; Gapany M; Gapany S; Barker EA; Preisler HD
Cancer Res; 1992 May; 52(9):2597-602. PubMed ID: 1348967
[TBL] [Abstract][Full Text] [Related]
8. [Relationship between Helicobacter pylori infection and expression of c-myc, Bcl-2, and Bax protein in different gastric mucosa lesions].
Zhan N; Xiong YY; Lan J; Wang BC; Tian SF; Yu SP
Ai Zheng; 2003 Oct; 22(10):1034-7. PubMed ID: 14558945
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analysis of the expression of the c-myc oncoprotein in human stomach cancers.
Spandidos DA; Karayiannis M; Yiagnisis M; Papadimitriou K; Field JK
Digestion; 1991; 50(3-4):127-34. PubMed ID: 1812039
[TBL] [Abstract][Full Text] [Related]
10. Oncoprotein (c-myc, c-erbB1, c-erbB2, c-fos) and suppressor gene product (p53) expression in squamous cell carcinomas of the lung. Clinical and biological correlations.
Volm M; Efferth T; Mattern J
Anticancer Res; 1992; 12(1):11-20. PubMed ID: 1348920
[TBL] [Abstract][Full Text] [Related]
11. Protein expression and molecular analysis of c-myc gene in primary breast carcinomas using immunohistochemistry and differential polymerase chain reaction.
Naidu R; Wahab NA; Yadav M; Kutty MK
Int J Mol Med; 2002 Feb; 9(2):189-96. PubMed ID: 11786932
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical study of oncogene product ras p21, c-myc and growth factor EGF in breast carcinomas.
Mizukami Y; Nonomura A; Noguchi M; Taniya T; Koyasaki N; Saito Y; Hashimoto T; Matsubara F; Yanaihara N
Anticancer Res; 1991; 11(4):1485-94. PubMed ID: 1660689
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical detection of c-myc products in colorectal cancer and proliferative cell rate.
Yamaguchi A; Ninomiya I; Ishida T; Nishimura G; Kanno M; Yonemura Y; Miwa K; Miyazaki I; Matsukawa S
Oncology; 1992; 49(1):40-4. PubMed ID: 1542492
[TBL] [Abstract][Full Text] [Related]
14. Expression of C-myc and β-catenin and their correlation in triple negative breast cancer.
Wang J; Li M; Chen D; Nie J; Xi Y; Yang X; Chen Y; Yang Z
Minerva Med; 2017 Dec; 108(6):513-517. PubMed ID: 28889723
[TBL] [Abstract][Full Text] [Related]
15. THE CANONICAL WNT PATHWAY IN GASTRIC CARCINOMA.
Oliveira LA; Oshima CTF; Soffner PA; Silva MS; Lins RR; Malinverni ACM; Waisberg J
Arq Bras Cir Dig; 2019 Jan; 32(1):e1414. PubMed ID: 30624523
[TBL] [Abstract][Full Text] [Related]
16. The expression of EGF receptors, EGF-like factors and c-myc in ovarian and cervical carcinomas and their potential clinical significance.
Kohler M; Janz I; Wintzer HO; Wagner E; Bauknecht T
Anticancer Res; 1989; 9(6):1537-47. PubMed ID: 2697181
[TBL] [Abstract][Full Text] [Related]
17. Oncogenes and male breast carcinoma: c-erbB-2 and p53 coexpression predicts a poor survival.
Pich A; Margaria E; Chiusa L
J Clin Oncol; 2000 Aug; 18(16):2948-56. PubMed ID: 10944127
[TBL] [Abstract][Full Text] [Related]
18. The relation between the growth patterns of gastric carcinoma and the expression of hepatocyte growth factor receptor (c-met), autocrine motility factor receptor, and urokinase-type plasminogen activator receptor.
Taniguchi K; Yonemura Y; Nojima N; Hirono Y; Fushida S; Fujimura T; Miwa K; Endo Y; Yamamoto H; Watanabe H
Cancer; 1998 Jun; 82(11):2112-22. PubMed ID: 9610690
[TBL] [Abstract][Full Text] [Related]
19. [Gene expression in gastric carcinoma tissues].
Onoda N
Nihon Geka Gakkai Zasshi; 1995 Jun; 96(6):362-9. PubMed ID: 7666851
[TBL] [Abstract][Full Text] [Related]
20. Expression of p53 protein in normal, dysplastic, and malignant gastric mucosa: an immunohistochemical study.
Joypaul BV; Newman EL; Hopwood D; Grant A; Qureshi S; Lane DP; Cuschieri A
J Pathol; 1993 Jul; 170(3):279-83. PubMed ID: 8133401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
